MYC and head and neck squamous cell carcinoma: Our findings highlight the need for more work interrogating MYC-mediated mechanisms of acquired resistance to immunotherapy in HNSCC, as well as potential combinatorial therapeutic strategies to target the cellular processes that drive this therapeutic resistance24,33,34.